Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tor

Showing results (81-90 of 155) with videos related to

Pageof 16
Sort By:
Medicina Clinica|March 18, 1995
[Tumor necrosis factor-alpha in human immunodeficiency virus infection]P Llobet, R Muga, J A González, et al.
Archives of Internal Medicine|April 1, 1986
HTLV-III antibody in intravenous drug abusers of metropolitan Barcelona, SpainJ Tor, R Muga, E Argelagues, et al.
Revista Clinica Espanola|February 28, 1983
[Hepatic percutaneous biopsy in lymphoma]J Tor, J Vilaseca, J R Duran, et al.
Medicina Clinica|September 9, 1989
[Evidence of infection by type 2 (HIV 2) human immunodeficiency virus in heroin addicts in Barcelona]V Soriano, J Tor, A Ribera, et al.
Medicina Clinica|March 3, 1984
[Yersinia enterocolitica hepatic granulomatosis]A Guarga, A Urrutia, J Tor, et al.
Medicina Clinica|May 19, 1990
[HTLV-I in patients from Barcelona with connective tissue diseases, neurologic demyelinating diseases and lymphoproliferative syndromes]V Soriano, J Tor, J M Ribera, et al.
Journal of Viral Hepatitis|August 19, 2014
Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patientsD Fuster, A Sanvisens, F Bolao, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|October 1, 1989
[Difficulties in research on antibodies to HTLV-I]V Soriano, J Tor, A Ribera, et al.
Current HIV Research|December 29, 2010
Use of highly active antiretroviral therapy is increasing in HIV positive severe drug usersG Vallecillo, A Sanvisens, E Martinez, et al.
Medicina Clinica|October 10, 1981
[Determination of serum activity of glucose phosphate isomerase and glutathione reductase in intra and extra hepatic cholestasis.(author's transl)]J Tor, R M Segura, C Pascual, et al.
Pageof 16

Showing results (81-90 of 155) with videos related to

Sort By:
Pageof 16
Medicina Clinica|March 18, 1995
[Tumor necrosis factor-alpha in human immunodeficiency virus infection]P Llobet, R Muga, J A González, et al.
Archives of Internal Medicine|April 1, 1986
HTLV-III antibody in intravenous drug abusers of metropolitan Barcelona, SpainJ Tor, R Muga, E Argelagues, et al.
Revista Clinica Espanola|February 28, 1983
[Hepatic percutaneous biopsy in lymphoma]J Tor, J Vilaseca, J R Duran, et al.
Medicina Clinica|September 9, 1989
[Evidence of infection by type 2 (HIV 2) human immunodeficiency virus in heroin addicts in Barcelona]V Soriano, J Tor, A Ribera, et al.
Medicina Clinica|March 3, 1984
[Yersinia enterocolitica hepatic granulomatosis]A Guarga, A Urrutia, J Tor, et al.
Medicina Clinica|May 19, 1990
[HTLV-I in patients from Barcelona with connective tissue diseases, neurologic demyelinating diseases and lymphoproliferative syndromes]V Soriano, J Tor, J M Ribera, et al.
Journal of Viral Hepatitis|August 19, 2014
Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patientsD Fuster, A Sanvisens, F Bolao, et al.
Anales De Medicina Interna (Madrid, Spain : 1984)|October 1, 1989
[Difficulties in research on antibodies to HTLV-I]V Soriano, J Tor, A Ribera, et al.
Current HIV Research|December 29, 2010
Use of highly active antiretroviral therapy is increasing in HIV positive severe drug usersG Vallecillo, A Sanvisens, E Martinez, et al.
Medicina Clinica|October 10, 1981
[Determination of serum activity of glucose phosphate isomerase and glutathione reductase in intra and extra hepatic cholestasis.(author's transl)]J Tor, R M Segura, C Pascual, et al.
Pageof 16